A 41-year-old Emirati FH patient with 9.4 mmol/L on lipid-lowering treatment (20 mg Simvastatin +10 mg Ezetimibe) was identified as a compound heterozygote carrying p.D178N and p.C243Y in LDLR (Rimbert et al., 2022). Here, LDLR is linked to familial hyperaldosteronism.